Nepafenac ophthalmic suspension vehicle

OTHER3 trials

Sponsors

Alcon Research

Conditions

CataractDiabetic RetinopathyMacular Edema

Phase 2

A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients

CompletedNCT00782717

Alcon ResearchMacular Edema

Start: 2008-11-30End: 2010-07-31Updated: 2012-10-26

Phase 3

Nevanac 3-Month Safety Study With QID Dosing

CompletedNCT00332774

Alcon ResearchCataract

Start: 2006-02-28End: 2006-12-31Updated: 2012-03-05

Macular Edema Incidence/Severity Reduction With Nevanac

TerminatedNCT00939276

Alcon ResearchDiabetic Retinopathy

Start: 2009-08-31End: 2011-08-31Updated: 2012-10-23

Related Papers

Prospective randomised clinical trial to evaluate the safety and efficacy of nepafenac 0.1% treatment for the prevention of macular oedema associated with cataract surgery in patients with diabetic retinopathy

British Journal of Ophthalmology2016-07-0741 citations